Skip to main content

Table 1 Main characteristics of the eligible studies

From: Prognostic value of lymph node ratio in laryngeal and hypopharyngeal squamous cell carcinoma: a systematic review and meta-analysis

Study

Year

Region

Study period

Type of study

Population

Endpoints with HR

LNR cut-off

Method of LNR determination

Follow-up time (months)

Ye [22]

2018

China

2007 to 2016

retrospective

HPSCC

OS, DFS

<0.07,≥0.07

ROC

Median 33.1

(6.1 to 110.7)

Lo [15]

2017

Taipei, China

2001 to 2007

retrospective

HPSCC

OS, DFS, DSS

< 0.113, ≥0.113

Mean

Mean 51

(4 to 144)

Suzuki [21]

2016

Japan

2000 to 2015

prospective

HPSCC

OS, DFS

< 0.09, ≥0.09

Log-rank test

Mean ± SD

45.7 ± 40.6

Joo [14]

2015

Korea

1993 to 2014

retrospective

HPSCC

OS, DFS

< 0.055, ≥0.055

ROC

Mean 37

(1 to 151)

Hua [13]

2015

China

2000 to 2005

retrospective

HPSCC

OS

< 10, > 10%

NA

Median 48

(12 to 127)

Yu [29]

2013

China

1965 to 2008

retrospective

HPSCC

OS, DFS, DSS

≤0.14, > 0.14

LNR quartiles

Mean 41.8

(1 to 295)

Wang [27]

2013

SEER

1988 to 2008

retrospective

HPSCC

OS, DFS

0–0.05, 0.05–0.30, > 0.30

Log-rank test

Median 23

(0 to 238)

Imre [19]

2016

Turkey

2006 to 2014

retrospective

LSCC

OS, DFS

< 0.09, ≥0.09

Univariate Cox analysis

Mean 33.5

(6 to 94)

Ryu [16]

2015

Korea

2001 to 2010

retrospective

LSCC

DFS

≤0.044, > 0.044

ROC

Median 53.2

(2.1 to 147.1)

Wang [28]

2014

SEER

1988 to 2008

retrospective

LSCC

OS, DFS

0–0.09, 0.09–0.20, > 0.20

Log-rank test

NA

Künzel [20]

2015

Germany

1980 to 2010

retrospective

LSCC

DFS

< 0.09, > 0.09/< 0.09, > 0.09

ROC

Mean 53

(0.1 to 229)

Choi [12]

2019

Germany

2006 to 2016

retrospective

HPSCC/LSCC

OS, DFS, DSS

0.03

ROC

Median 60

(24 to 134)

Grasl [18]

2019

Austria

1994 to 2018

retrospective

HPSCC/LSCC

OS, DFS, DSS

≤0.07, > 0.07

ROC

Mean ± SD

55.6 ± 59.3

  1. HPSCC hypopharyngeal squamous cell carcinoma, LSCC laryngeal squamous cell carcinoma, OS overall survival, DSS disease-specific survival, DFS disease-free survival, ROC receiver operating characteristic; NA: not available